EBIT: Income before interest and taxes.
Crinetics Pharmaceuticals, Inc. (CRNX) had EBIT of $-129.11M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$1.03M |
|
$-115.64M |
|
-- |
|
$1.03M |
|
$130.14M |
|
$-129.11M |
|
$13.47M |
|
$-115.64M |
|
$-115.64M |
|
$-115.64M |
|
$-115.64M |
|
$-115.64M |
|
$-115.64M |
|
|
EBIT |
$-129.11M |
$-132.87M |
|
93.79M |
|
93.79M |
|
$-1.23 |
|
$-1.23 |
|
| Balance Sheet Financials | |
$1.22B |
|
$14.67M |
|
$72.31M |
|
$1.29B |
|
$68.40M |
|
-- |
|
$49.65M |
|
$118.05M |
|
$1.17B |
|
$1.17B |
|
$1.17B |
|
94.13M |
|
| Cash Flow Statement Financials | |
$-174.30M |
|
$-48.01M |
|
$11.49M |
|
$265.85M |
|
$55.03M |
|
$-210.82M |
|
$46.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-12522.99% |
|
-12522.99% |
|
-- |
|
-11216.00% |
|
-11216.00% |
|
$-178.74M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-9.87% |
|
-9.87% |
|
-8.97% |
|
-9.87% |
|
$12.45 |
|
$-1.91 |
|
$-1.86 |
|